Verition Fund Management LLC Uro Gen Pharma Ltd. Transaction History

Verition Fund Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$10.52 - $13.11 $162,197 - $202,129	15,418 Added 116.33%	28,672 $305,000
Q3 2024 Nov 14, 2024	BUY	$12.7 - $17.92 $168,325 - $237,511	13,254 New	13,254 $168,000
Q3 2023 Nov 14, 2023	BUY	$8.84 - $22.64 $150,430 - $385,264	17,017 New	17,017 $238,000

139

37.7M

91.4K

42.1K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $182M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.